Neelkanth Drugs Private Limited, a amalgamated private limited company, was established on 19 April 1999 in Ameerpet, Telangana, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24233TS1999PTC173960. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹2.90 Cr.
It upholds a compliant status. Employing 467 professional, Its leadership includes Arvind Kumar Venkat (Nominee Director), Vardaan Sharma (Director), Yashwant Singh (Nominee Director). Past directors included Arvind Kumar Venkat, Taruna Chimanlal Joshi, Ved Prakash Saini. It holds no open charges and ₹213.59 Cr settled loans. Its latest AGM occurred on 09 August 2023, with the balance sheet filed on 31 March 2023. It is based at D.No 7-2-1740, K,Subbaiah Pillai, Godowns, Main Road,Sanath Nagar, Ameerpet, Telangana, 500018.
U24233TS1999PTC173960
173960
19 April 1999
₹3.00 Cr
₹2.90 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Neelkanth Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Arvind Kumar Venkat | Nominee Director | 29 Jun 2011 | Current |
| Vardaan Sharma | Director | 31 Aug 2017 | Current |
| Yashwant Singh | Nominee Director | 31 Jul 2018 | Current |
| Pramod Kumar Sharma | Managing Director | 15 Oct 2004 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Jan 2020 | Past |
| Pramod Abcsdd | Director | 03 May 2018 | Past |
| Pramod Abcsdd | Director | 31 Aug 2017 | Past |
| Pramod Abcsdd | Director | 29 Jun 2011 | Past |
| Pramod Abcsdd | Director | 29 Jun 2011 | Past |
| Pramod Abcsdd | Director | 01 Apr 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neelkanth Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 38.28% increase. The company also saw a substantial fall in profitability, with a 44.75% decrease in profit. The company's net worth moved up by a moderate rise of 0.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Neelkanth Drugs had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,135,940,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2020 | Hdfc Bank Limited | ₹90.00 Cr | Satisfied |
| 20 Dec 2018 | Others | ₹50.00 Cr | Satisfied |
| 16 Sep 2017 | Hdfc Bank Limited | ₹6.30 M | Satisfied |
| 30 Jun 2017 | Others | ₹2.82 M | Satisfied |
| 20 Nov 2014 | Hdfc Bank Limited | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Neelkanth Drugs has a workforce of 467 employees as of May 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Neelkanth Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neelkanth Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 12 Aug 2011 via Charge ID 10309932 with The Nainital Bank Limited was fully satisfied on 18 Dec 2023. was documented.
The activity A charge registered on 16 Sep 2017 via Charge ID 100144950 with Hdfc Bank Limited was fully satisfied on 16 Dec 2023. was completed.
The activity A charge registered on 30 Jun 2017 via Charge ID 100141906 with Others was fully satisfied on 13 Dec 2023. was completed.
Progress on Neelkanth Drugs Private Limited last Annual general meeting of members was held on 09 Aug 2023 as per latest MCA records. was documented.
Progress on A charge registered on 29 Jun 2020 via Charge ID 100346758 with Hdfc Bank Limited was fully satisfied on 03 Aug 2023. was documented.
The activity Neelkanth Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was completed.
The CIN of Neelkanth Drugs Private Limited is U24233TS1999PTC173960.
Neelkanth Drugs Private Limited is headquartered at D.No 7-2-1740, K,Subbaiah Pillai, Godowns, Main Road,Sanath Nagar, Ameerpet, Telangana, 500018.
Neelkanth Drugs Private Limited was incorporated on 19 April 1999.
The current directors of Neelkanth Drugs Private Limited are
The primary industry of Neelkanth Drugs Private Limited is Trade.
Neelkanth Drugs Private Limited is unlisted.
The authorized capital of Neelkanth Drugs Private Limited is ₹3.00 Cr, and the paid-up capital is ₹2.90 Cr.
The compliance status of Neelkanth Drugs Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX